tirzepatide semaglutide weight loss comparison vs Tirzepatide: Which GLP-1 Wins for Loss? ✨ Semaglutide vs. Tirzepatide —

GLP-1 medications may help address menopause-related weight gain by regulating appetite and metabolism, but individual response depends on hormonal status, metabolic biomarkers, and genetic predispositions

GLP-1 drugs have not shown as strong an uptake in Europe as in the US

Using GLP-1RAs or SGLT2is was associated with an insignificantly lower NAFLD/NASH risk (i.e., odds ratios [95% CIs]: 0.84 [0.461.52] and 0.85 [0.631.14], respectively) and increased cumulative SGLT2i doses were significantly associated with a reduced NAFLD/NASH risk (0.61 [0.380.97])

To further note, in the field of weight-loss treatment, significant work is underway in parallel, on GIP agonist, amylin agonist, glucagon agonist, PYY agonist, either separately or in combination especially with GLP-1 agonist.

No alternative reversible etiology for bowel obstruction was identified

THRIVE myGLP Dissolvable GLP-1 Activation Technology oral strips - a new way to support your weight management on-the-go for when you need natural GLP support.